세계의 치매 치료 시장 : 규모, 점유율, 동향 분석 보고서 - 유형별, 치매 치료제 투여 경로별, 치매 치료제 유통 채널별, 적응증별, 지역별 전망 및 예측(2024-2031년)

The Global Dementia Treatment Market size is expected to reach $29.2 billion by 2031, rising at a market growth of 7.4% CAGR during the forecast period.

Alzheimer's disease is one of the most prevalent forms of dementia, responsible for a substantial proportion of dementia cases worldwide. As the disease progresses, individuals may experience confusion, mood swings, difficulty completing familiar tasks, and changes in personality and behavior. Hence, Alzheimer's disease dementia captured 58% revenue share in the market in the year 2031. The symptoms of Alzheimer's disease typically begin gradually and worsen over time. In the later stages of the disease, individuals may require round-the-clock care as they lose the ability to communicate and care for themselves.

The increasing number of elderly people around the world is one of the most important factors that is driving the expansion of the market for dementia treatments. Individuals all over the world are living longer. As advancements in healthcare and living standards continue to extend life expectancy, the proportion of elderly individuals within populations is increasing. Consequently, the rising number of elderly individuals is leading to a higher incidence of dementia, necessitating effective treatment options and driving the growth of the market.

Additionally, the increasing prevalence of dementia and related conditions is a substantial global health concern that affects millions of individuals and their families. Dementia is currently affecting approximately 55 million individuals worldwide, according to the World Health Organisation (WHO). The increasing prevalence of dementia is fueling demand for effective treatments and interventions. People with dementia are increasingly in need of comprehensive healthcare strategies that encompass supportive care, effective medical treatments, and early diagnosis. Thus, the rising prevalence of dementia will aid in expanding the market.

However, Dementia care involves various medical, social, and supportive services, including medications, doctor visits, home care, and residential care. These expenses can accumulate rapidly, particularly as the disease advances and the necessity for care increases. Long-term care and support services can be particularly expensive, such as nursing home care or in-home care by trained professionals. This financial strain can be particularly severe in regions with limited access to affordable healthcare services, leading to delays in seeking care or inadequate treatment. Hence, the high cost of dementia treatments may hamper the market's growth.

Initially, the pandemic disrupted healthcare systems worldwide, diverting resources and attention away from non-COVID-19-related conditions, including dementia. This diversion resulted in delays in diagnosis and treatment for many dementia patients, leading to worsening symptoms and outcomes. On the other hand, the pandemic accelerated the adoption of telehealth and digital health technologies in dementia care, presenting new opportunities for industry. The integration of these technologies into dementia care not only mitigated the impact of the pandemic but also improved access to care for patients in rural or underserved areas. Therefore, the pandemic had an overall moderate impact on the market.

Type Outlook

Based on type, the market is bifurcated into diagnosis and drugs. The drugs segment garnered 60% revenue share in the market in 2023. Patients with Alzheimer's disease or any other form of dementia frequently employ pharmacological treatments, such as cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists, to alleviate symptoms and enhance cognitive function. The availability of these drugs, along with ongoing research and development activities aimed at developing new and more effective therapies, has driven the growth of the drugs segment in the market.

Route of Administration Outlook

Based on dementia drugs route of administration, the market is segmented into oral, transdermal patch, and injectable. The oral segment procured the 32% share in the market in 2023. Oral medications are the most prevalent method of administration for dementia drugs, providing patients and carers with convenience and ease of use. Drugs such as cholinesterase inhibitors and NMDA receptor antagonists are typically administered orally, allowing for regular dosing and consistent blood levels, which are crucial for maintaining therapeutic effects in dementia management.

Distribution Channel Outlook

On the basis of dementia drugs distribution channel, the market is divided into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment witnessed 16% revenue share in the market in 2023. Retail pharmacies, including chain pharmacies, independent pharmacies, and drug stores, are important sources of dementia medication for community patients. These pharmacies provide essential medications and counseling services for managing dementia symptoms and treatment regimens, providing convenience and accessibility for patients and carers.

Indication Outlook

By indication, the market is segmented into Alzheimer's disease dementia, vascular dementia, Lewy body dementia, frontotemporal dementia (FTD), Parkinson disease dementia, and others. The Parkinson disease dementia segment procured 15% revenue share in the market in 2023. Parkinson's disease dementia is a common complication of Parkinson's disease, affecting a significant number of individuals with the condition.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded 39% revenue share in the market in 2023. The growth of the market in this region can be attributed to a large elderly population, high healthcare spending, and advanced healthcare infrastructure in countries such as the United States and Canada. These factors contribute to the widespread availability of dementia treatments and services.

List of Key Companies Profiled

• Eisai Co., Ltd.
• Eli Lilly And Company
• F. Hoffmann-La Roche Ltd.
• Biogen, Inc.
• AbbVie, Inc.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• GlaxoSmithKline PLC (GSK)
• Cipla Limited

Global Dementia Treatment Market Report Segmentation

By Type

• Diagnosis
  • Imaging Techniques
  • Cognitive Assessment Tools
  • Genetic Testing
  • Biomarker Analysis
  • Others
• Drugs
  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonist
  • MAO Inhibitors
  • Combination Drug
  • Others

By Dementia Drugs Route of Administration

• Oral
• Transdermal Patch
• Injectable

By Dementia Drugs Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Indication

• Alzheimer's Disease Dementia
• Vascular Dementia
• Lewy Body Dementia
• Frontotemporal Dementia (FTD)
• Parkinson Disease Dementia
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Dementia Treatment Market, by Type
  • 1.4.2 Global Dementia Treatment Market, by Dementia Drugs Route of Administration
  • 1.4.3 Global Dementia Treatment Market, by Dementia Drugs Distribution Channel
  • 1.4.4 Global Dementia Treatment Market, by Indication
  • 1.4.5 Global Dementia Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Dementia Treatment Market by Type

• 4.1 Global Diagnosis Market by Region
• 4.2 Global Dementia Treatment Market by Diagnosis Type
  • 4.2.1 Global Imaging Techniques Market by Region
  • 4.2.2 Global Cognitive Assessment Tools Market by Region
  • 4.2.3 Global Genetic Testing Market by Region
  • 4.2.4 Global Biomarker Analysis Market by Region
  • 4.2.5 Global Others Market by Region
• 4.3 Global Drugs Market by Region
• 4.4 Global Dementia Treatment Market by Drug Class
  • 4.4.1 Global Cholinesterase Inhibitors Market by Region
  • 4.4.2 Global NMDA Receptor Antagonist Market by Region
  • 4.4.3 Global MAO Inhibitors Market by Region
  • 4.4.4 Global Combination Drug Market by Region
  • 4.4.5 Global Others Market by Region

Chapter 5. Global Dementia Treatment Market by Dementia Drugs Route of Administration

• 5.1 Global Oral Market by Region
• 5.2 Global Transdermal Patch Market by Region
• 5.3 Global Injectable Market by Region

Chapter 6. Global Dementia Treatment Market by Dementia Drugs Distribution Channel

• 6.1 Global Hospital Pharmacy Market by Region
• 6.2 Global Retail Pharmacy Market by Region
• 6.3 Global Online Pharmacy Market by Region

Chapter 7. Global Dementia Treatment Market by Indication

• 7.1 Global Alzheimer's Disease Dementia Market by Region
• 7.2 Global Vascular Dementia Market by Region
• 7.3 Global Lewy Body Dementia Market by Region
• 7.4 Global Frontotemporal Dementia (FTD) Market by Region
• 7.5 Global Parkinson Disease Dementia Market by Region
• 7.6 Global Others Market by Region

Chapter 8. Global Dementia Treatment Market by Region

• 8.1 North America Dementia Treatment Market
  • 8.1.1 North America Dementia Treatment Market by Type
    • 8.1.1.1 North America Diagnosis Market by Region
    • 8.1.1.2 North America Dementia Treatment Market by Diagnosis Type
      • 8.1.1.2.1 North America Imaging Techniques Market by Country
      • 8.1.1.2.2 North America Cognitive Assessment Tools Market by Country
      • 8.1.1.2.3 North America Genetic Testing Market by Country
      • 8.1.1.2.4 North America Biomarker Analysis Market by Country
      • 8.1.1.2.5 North America Others Market by Country
    • 8.1.1.3 North America Drugs Market by Region
    • 8.1.1.4 North America Dementia Treatment Market by Drug Class
      • 8.1.1.4.1 North America Cholinesterase Inhibitors Market by Country
      • 8.1.1.4.2 North America NMDA Receptor Antagonist Market by Country
      • 8.1.1.4.3 North America MAO Inhibitors Market by Country
      • 8.1.1.4.4 North America Combination Drug Market by Country
      • 8.1.1.4.5 North America Others Market by Country
  • 8.1.2 North America Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.1.2.1 North America Oral Market by Country
    • 8.1.2.2 North America Transdermal Patch Market by Country
    • 8.1.2.3 North America Injectable Market by Country
  • 8.1.3 North America Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.1.3.1 North America Hospital Pharmacy Market by Country
    • 8.1.3.2 North America Retail Pharmacy Market by Country
    • 8.1.3.3 North America Online Pharmacy Market by Country
  • 8.1.4 North America Dementia Treatment Market by Indication
    • 8.1.4.1 North America Alzheimer's Disease Dementia Market by Country
    • 8.1.4.2 North America Vascular Dementia Market by Country
    • 8.1.4.3 North America Lewy Body Dementia Market by Country
    • 8.1.4.4 North America Frontotemporal Dementia (FTD) Market by Country
    • 8.1.4.5 North America Parkinson Disease Dementia Market by Country
    • 8.1.4.6 North America Others Market by Country
  • 8.1.5 North America Dementia Treatment Market by Country
    • 8.1.5.1 US Dementia Treatment Market
      • 8.1.5.1.1 US Dementia Treatment Market by Type
      • 8.1.5.1.2 US Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.1.5.1.3 US Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.1.5.1.4 US Dementia Treatment Market by Indication
    • 8.1.5.2 Canada Dementia Treatment Market
      • 8.1.5.2.1 Canada Dementia Treatment Market by Type
      • 8.1.5.2.2 Canada Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.1.5.2.3 Canada Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.1.5.2.4 Canada Dementia Treatment Market by Indication
    • 8.1.5.3 Mexico Dementia Treatment Market
      • 8.1.5.3.1 Mexico Dementia Treatment Market by Type
      • 8.1.5.3.2 Mexico Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.1.5.3.3 Mexico Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.1.5.3.4 Mexico Dementia Treatment Market by Indication
    • 8.1.5.4 Rest of North America Dementia Treatment Market
      • 8.1.5.4.1 Rest of North America Dementia Treatment Market by Type
      • 8.1.5.4.2 Rest of North America Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.1.5.4.3 Rest of North America Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.1.5.4.4 Rest of North America Dementia Treatment Market by Indication
• 8.2 Europe Dementia Treatment Market
  • 8.2.1 Europe Dementia Treatment Market by Type
    • 8.2.1.1 Europe Diagnosis Market by Country
    • 8.2.1.2 Europe Dementia Treatment Market by Diagnosis Type
      • 8.2.1.2.1 Europe Imaging Techniques Market by Country
      • 8.2.1.2.2 Europe Cognitive Assessment Tools Market by Country
      • 8.2.1.2.3 Europe Genetic Testing Market by Country
      • 8.2.1.2.4 Europe Biomarker Analysis Market by Country
      • 8.2.1.2.5 Europe Others Market by Country
    • 8.2.1.3 Europe Drugs Market by Country
    • 8.2.1.4 Europe Dementia Treatment Market by Drug Class
      • 8.2.1.4.1 Europe Cholinesterase Inhibitors Market by Country
      • 8.2.1.4.2 Europe NMDA Receptor Antagonist Market by Country
      • 8.2.1.4.3 Europe MAO Inhibitors Market by Country
      • 8.2.1.4.4 Europe Combination Drug Market by Country
      • 8.2.1.4.5 Europe Others Market by Country
  • 8.2.2 Europe Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.2.2.1 Europe Oral Market by Country
    • 8.2.2.2 Europe Transdermal Patch Market by Country
    • 8.2.2.3 Europe Injectable Market by Country
  • 8.2.3 Europe Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.2.3.1 Europe Hospital Pharmacy Market by Country
    • 8.2.3.2 Europe Retail Pharmacy Market by Country
    • 8.2.3.3 Europe Online Pharmacy Market by Country
  • 8.2.4 Europe Dementia Treatment Market by Indication
    • 8.2.4.1 Europe Alzheimer's Disease Dementia Market by Country
    • 8.2.4.2 Europe Vascular Dementia Market by Country
    • 8.2.4.3 Europe Lewy Body Dementia Market by Country
    • 8.2.4.4 Europe Frontotemporal Dementia (FTD) Market by Country
    • 8.2.4.5 Europe Parkinson Disease Dementia Market by Country
    • 8.2.4.6 Europe Others Market by Country
  • 8.2.5 Europe Dementia Treatment Market by Country
    • 8.2.5.1 Germany Dementia Treatment Market
      • 8.2.5.1.1 Germany Dementia Treatment Market by Type
      • 8.2.5.1.2 Germany Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.1.3 Germany Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.1.4 Germany Dementia Treatment Market by Indication
    • 8.2.5.2 UK Dementia Treatment Market
      • 8.2.5.2.1 UK Dementia Treatment Market by Type
      • 8.2.5.2.2 UK Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.2.3 UK Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.2.4 UK Dementia Treatment Market by Indication
    • 8.2.5.3 France Dementia Treatment Market
      • 8.2.5.3.1 France Dementia Treatment Market by Type
      • 8.2.5.3.2 France Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.3.3 France Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.3.4 France Dementia Treatment Market by Indication
    • 8.2.5.4 Russia Dementia Treatment Market
      • 8.2.5.4.1 Russia Dementia Treatment Market by Type
      • 8.2.5.4.2 Russia Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.4.3 Russia Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.4.4 Russia Dementia Treatment Market by Indication
    • 8.2.5.5 Spain Dementia Treatment Market
      • 8.2.5.5.1 Spain Dementia Treatment Market by Type
      • 8.2.5.5.2 Spain Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.5.3 Spain Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.5.4 Spain Dementia Treatment Market by Indication
    • 8.2.5.6 Italy Dementia Treatment Market
      • 8.2.5.6.1 Italy Dementia Treatment Market by Type
      • 8.2.5.6.2 Italy Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.6.3 Italy Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.6.4 Italy Dementia Treatment Market by Indication
    • 8.2.5.7 Rest of Europe Dementia Treatment Market
      • 8.2.5.7.1 Rest of Europe Dementia Treatment Market by Type
      • 8.2.5.7.2 Rest of Europe Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.2.5.7.3 Rest of Europe Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.2.5.7.4 Rest of Europe Dementia Treatment Market by Indication
• 8.3 Asia Pacific Dementia Treatment Market
  • 8.3.1 Asia Pacific Dementia Treatment Market by Type
    • 8.3.1.1 Asia Pacific Diagnosis Market by Country
    • 8.3.1.2 Asia Pacific Dementia Treatment Market by Diagnosis Type
      • 8.3.1.2.1 Asia Pacific Imaging Techniques Market by Country
      • 8.3.1.2.2 Asia Pacific Cognitive Assessment Tools Market by Country
      • 8.3.1.2.3 Asia Pacific Genetic Testing Market by Country
      • 8.3.1.2.4 Asia Pacific Biomarker Analysis Market by Country
      • 8.3.1.2.5 Asia Pacific Others Market by Country
    • 8.3.1.3 Asia Pacific Drugs Market by Country
    • 8.3.1.4 Asia Pacific Dementia Treatment Market by Drug Class
      • 8.3.1.4.1 Asia Pacific Cholinesterase Inhibitors Market by Country
      • 8.3.1.4.2 Asia Pacific NMDA Receptor Antagonist Market by Country
      • 8.3.1.4.3 Asia Pacific MAO Inhibitors Market by Country
      • 8.3.1.4.4 Asia Pacific Combination Drug Market by Country
      • 8.3.1.4.5 Asia Pacific Others Market by Country
  • 8.3.2 Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.3.2.1 Asia Pacific Oral Market by Country
    • 8.3.2.2 Asia Pacific Transdermal Patch Market by Country
    • 8.3.2.3 Asia Pacific Injectable Market by Country
  • 8.3.3 Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
    • 8.3.3.2 Asia Pacific Retail Pharmacy Market by Country
    • 8.3.3.3 Asia Pacific Online Pharmacy Market by Country
  • 8.3.4 Asia Pacific Dementia Treatment Market by Indication
    • 8.3.4.1 Asia Pacific Alzheimer's Disease Dementia Market by Country
    • 8.3.4.2 Asia Pacific Vascular Dementia Market by Country
    • 8.3.4.3 Asia Pacific Lewy Body Dementia Market by Country
    • 8.3.4.4 Asia Pacific Frontotemporal Dementia (FTD) Market by Country
    • 8.3.4.5 Asia Pacific Parkinson Disease Dementia Market by Country
    • 8.3.4.6 Asia Pacific Others Market by Country
  • 8.3.5 Asia Pacific Dementia Treatment Market by Country
    • 8.3.5.1 China Dementia Treatment Market
      • 8.3.5.1.1 China Dementia Treatment Market by Type
      • 8.3.5.1.2 China Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.1.3 China Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.1.4 China Dementia Treatment Market by Indication
    • 8.3.5.2 Japan Dementia Treatment Market
      • 8.3.5.2.1 Japan Dementia Treatment Market by Type
      • 8.3.5.2.2 Japan Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.2.3 Japan Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.2.4 Japan Dementia Treatment Market by Indication
    • 8.3.5.3 India Dementia Treatment Market
      • 8.3.5.3.1 India Dementia Treatment Market by Type
      • 8.3.5.3.2 India Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.3.3 India Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.3.4 India Dementia Treatment Market by Indication
    • 8.3.5.4 South Korea Dementia Treatment Market
      • 8.3.5.4.1 South Korea Dementia Treatment Market by Type
      • 8.3.5.4.2 South Korea Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.4.3 South Korea Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.4.4 South Korea Dementia Treatment Market by Indication
    • 8.3.5.5 Singapore Dementia Treatment Market
      • 8.3.5.5.1 Singapore Dementia Treatment Market by Type
      • 8.3.5.5.2 Singapore Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.5.3 Singapore Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.5.4 Singapore Dementia Treatment Market by Indication
    • 8.3.5.6 Malaysia Dementia Treatment Market
      • 8.3.5.6.1 Malaysia Dementia Treatment Market by Type
      • 8.3.5.6.2 Malaysia Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.6.3 Malaysia Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.6.4 Malaysia Dementia Treatment Market by Indication
    • 8.3.5.7 Rest of Asia Pacific Dementia Treatment Market
      • 8.3.5.7.1 Rest of Asia Pacific Dementia Treatment Market by Type
      • 8.3.5.7.2 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.3.5.7.3 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.3.5.7.4 Rest of Asia Pacific Dementia Treatment Market by Indication
• 8.4 LAMEA Dementia Treatment Market
  • 8.4.1 LAMEA Dementia Treatment Market by Type
    • 8.4.1.1 LAMEA Diagnosis Market by Country
    • 8.4.1.2 LAMEA Dementia Treatment Market by Diagnosis Type
      • 8.4.1.2.1 LAMEA Imaging Techniques Market by Country
      • 8.4.1.2.2 LAMEA Cognitive Assessment Tools Market by Country
      • 8.4.1.2.3 LAMEA Genetic Testing Market by Country
      • 8.4.1.2.4 LAMEA Biomarker Analysis Market by Country
      • 8.4.1.2.5 LAMEA Others Market by Country
    • 8.4.1.3 LAMEA Drugs Market by Country
    • 8.4.1.4 LAMEA Dementia Treatment Market by Drug Class
      • 8.4.1.4.1 LAMEA Cholinesterase Inhibitors Market by Country
      • 8.4.1.4.2 LAMEA NMDA Receptor Antagonist Market by Country
      • 8.4.1.4.3 LAMEA MAO Inhibitors Market by Country
      • 8.4.1.4.4 LAMEA Combination Drug Market by Country
      • 8.4.1.4.5 LAMEA Others Market by Country
  • 8.4.2 LAMEA Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.4.2.1 LAMEA Oral Market by Country
    • 8.4.2.2 LAMEA Transdermal Patch Market by Country
    • 8.4.2.3 LAMEA Injectable Market by Country
  • 8.4.3 LAMEA Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.4.3.1 LAMEA Hospital Pharmacy Market by Country
    • 8.4.3.2 LAMEA Retail Pharmacy Market by Country
    • 8.4.3.3 LAMEA Online Pharmacy Market by Country
  • 8.4.4 LAMEA Dementia Treatment Market by Indication
    • 8.4.4.1 LAMEA Alzheimer's Disease Dementia Market by Country
    • 8.4.4.2 LAMEA Vascular Dementia Market by Country
    • 8.4.4.3 LAMEA Lewy Body Dementia Market by Country
    • 8.4.4.4 LAMEA Frontotemporal Dementia (FTD) Market by Country
    • 8.4.4.5 LAMEA Parkinson Disease Dementia Market by Country
    • 8.4.4.6 LAMEA Others Market by Country
  • 8.4.5 LAMEA Dementia Treatment Market by Country
    • 8.4.5.1 Brazil Dementia Treatment Market
      • 8.4.5.1.1 Brazil Dementia Treatment Market by Type
      • 8.4.5.1.2 Brazil Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.1.3 Brazil Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.1.4 Brazil Dementia Treatment Market by Indication
    • 8.4.5.2 Argentina Dementia Treatment Market
      • 8.4.5.2.1 Argentina Dementia Treatment Market by Type
      • 8.4.5.2.2 Argentina Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.2.3 Argentina Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.2.4 Argentina Dementia Treatment Market by Indication
    • 8.4.5.3 UAE Dementia Treatment Market
      • 8.4.5.3.1 UAE Dementia Treatment Market by Type
      • 8.4.5.3.2 UAE Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.3.3 UAE Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.3.4 UAE Dementia Treatment Market by Indication
    • 8.4.5.4 Saudi Arabia Dementia Treatment Market
      • 8.4.5.4.1 Saudi Arabia Dementia Treatment Market by Type
      • 8.4.5.4.2 Saudi Arabia Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.4.3 Saudi Arabia Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.4.4 Saudi Arabia Dementia Treatment Market by Indication
    • 8.4.5.5 South Africa Dementia Treatment Market
      • 8.4.5.5.1 South Africa Dementia Treatment Market by Type
      • 8.4.5.5.2 South Africa Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.5.3 South Africa Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.5.4 South Africa Dementia Treatment Market by Indication
    • 8.4.5.6 Nigeria Dementia Treatment Market
      • 8.4.5.6.1 Nigeria Dementia Treatment Market by Type
      • 8.4.5.6.2 Nigeria Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.6.3 Nigeria Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.6.4 Nigeria Dementia Treatment Market by Indication
    • 8.4.5.7 Rest of LAMEA Dementia Treatment Market
      • 8.4.5.7.1 Rest of LAMEA Dementia Treatment Market by Type
      • 8.4.5.7.2 Rest of LAMEA Dementia Treatment Market by Dementia Drugs Route of Administration
      • 8.4.5.7.3 Rest of LAMEA Dementia Treatment Market by Dementia Drugs Distribution Channel
      • 8.4.5.7.4 Rest of LAMEA Dementia Treatment Market by Indication

Chapter 9. Company Profiles

• 9.1 Eisai Co., Ltd.
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Segmental and Regional Analysis
  • 9.1.4 Research & Development Expenses
  • 9.1.5 Recent strategies and developments:
    • 9.1.5.1 Trails and Approval:
  • 9.1.6 SWOT Analysis
• 9.2 Eli Lilly And Company
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Regional Analysis
  • 9.2.4 Research & Development Expenses
  • 9.2.5 Recent strategies and developments:
    • 9.2.5.1 Acquisition and Mergers:
  • 9.2.6 SWOT Analysis
• 9.3 F. Hoffmann-La Roche Ltd.
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 Recent strategies and developments:
    • 9.3.5.1 Partnerships, Collaborations, and Agreements:
  • 9.3.6 SWOT Analysis
• 9.4 Biogen, Inc.
  • 9.4.1 Company Overview
  • 9.4.2 Financial Analysis
  • 9.4.3 Regional Analysis
  • 9.4.4 Research & Development Expense
  • 9.4.5 SWOT Analysis
• 9.5 AbbVie, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Financial Analysis
  • 9.5.3 Regional Analysis
  • 9.5.4 Research & Development Expense
  • 9.5.5 SWOT Analysis
• 9.6 Novartis AG
  • 9.6.1 Company Overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Segmental and Regional Analysis
  • 9.6.4 Research & Development Expense
  • 9.6.5 SWOT Analysis
• 9.7 Sun Pharmaceutical Industries Ltd.
  • 9.7.1 Company Overview
  • 9.7.2 Financial Analysis
  • 9.7.3 Regional Analysis
  • 9.7.4 Research & Development Expenses
  • 9.7.5 SWOT Analysis
• 9.8 Takeda Pharmaceutical Company Limited
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Regional Analysis
  • 9.8.4 Research & Development Expense
  • 9.8.5 SWOT Analysis
• 9.9 GlaxoSmithKline PLC (GSK)
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Regional Analysis
  • 9.9.4 Research & Development Expense
  • 9.9.5 SWOT Analysis
• 9.10. Cipla Limited
  • 9.10.1 Company Overview
  • 9.10.2 Financial Analysis
  • 9.10.3 Segmental and Regional Analysis
  • 9.10.4 Research & Development Expense
  • 9.10.5 SWOT Analysis

Chapter 10. Winning imperatives of Dementia Treatment Market